AZANTA DANMARK A/S
CVR: 25260279
Secondary names: NATIMMUNE A/S
The financial health of AZANTA DANMARK A/S appears robust, with a significant equity position of 313.45 million DKK as of 2024. However, revenue has shown a declining trend from 52.6 million DKK in 2020 to 22.73 million DKK in 2024, indicating a decrease in market demand or operational challenges. Despite this decline, profit margins remain strong, with a profit of 21.57 million DKK in 2024, suggesting effective cost management. The company’s position within the research and experimental development sector is notable, but the declining revenue trend raises concerns about its future growth trajectory.
AI-generated summary
Overview
- Company type
- A/S
- Aktieselskab
- Founded
- 17.3.2000
Details
- Employees
- 2 employees
- 1 FTE
- (2018)
- Capital
- 2.135.051 kr.
Contact
Advertising protected- Phone
- Log in to see
- Log in to see
- Website
- www.azanta.com
Purpose
Selskabets formål er at drive handel, produktion, udvikling og rådgivning indenfor den farmaceutiske virksomhed samt andet dermed beslægtet virksomhed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 22.7 mio. | 21.6 mio. | 336.8 mio. | 313.4 mio. | 1 | |
History
Ownership
Management
Directors
Board
Production units (1)
Similar companies
Companies in the same industry and area